Annual report [Section 13 and 15(d), not S-K Item 405]

Acquisitions and Related Arrangements - Pulmokine Acquisition (Details)

v3.26.1
Acquisitions and Related Arrangements - Pulmokine Acquisition (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Sep. 17, 2025
Nov. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Asset Acquisition        
Closing cash payment $ 98,968      
Amortization of intangible assets     $ 2,961 $ 206
Revenue from contracts with customers     10,350 6,650
Pulmokine        
Asset Acquisition        
Closing cash payment   $ 20,500    
Estimated useful life   12 years    
Amortization of intangible assets     2,200 200
Impairment of intangible asset     0  
Contract assets     0 0
Contract liabilities     0 0
Revenue from contracts with customers     $ 0 $ 0